Spots Global Cancer Trial Database for hematopoietic and lymphatic system neoplasm

Every month we try and update this database with for hematopoietic and lymphatic system neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
NCI COVID-19 in Cancer Patients, NCCAPS Study	NCT04387656	COVID-19 Infect... Hematopoietic a... Malignant Solid... Metastatic Mali...	Biospecimen Col... Data Collection Quality-of-Life... Questionnaire A...	-	National Cancer Institute (NCI)
Examining Arts as Therapy in Children With Cancer, CREATe Trial	NCT06342453	Hematopoietic a... Malignant Solid...	Art Therapy Discussion Media Intervent... Survey Administ...	8 Years - 13 Years	OHSU Knight Cancer Institute
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study	NCT02958462	Myeloid Maligna... Inherited Bone ... Clonal Expansio... Cytopenia Bone Marrow Fai... Clonal Cytopeni... Clonal Hematopo... Hematologic Neo... Hematopoietic a... Hereditary Neop... Idiopathic Cyto... Idiopathic Dysp... Low Risk Myelod...	Biospecimen Col... Bone Marrow Bio... Punch Biopsy Buccal Swab Clinical Evalua... Genetic Counsel... Quality-of-Life... Electronic Heal...	18 Years -	Mayo Clinic
Biomarkers to Predict Cancer Therapy-related Cardiotoxicity	NCT06353191	Hematopoietic a... Malignant Solid...	Non-Interventio...	18 Years -	Mayo Clinic
Testing GDC-0449 (Vismodegib) as Potentially Targeted Treatment in Cancers With Smoothened or Patched 1 Mutant Tumors (MATCH - Subprotocol T)	NCT06357988	Advanced Lympho... Advanced Malign... Hematopoietic a... Refractory Lymp... Refractory Mali... Refractory Mult...	Biopsy Biospecimen Col... Echocardiograph... Radionuclide Im... Vismodegib	18 Years -	National Cancer Institute (NCI)
Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer	NCT05228275	COVID-19 Infect... Hematopoietic a... Malignant Solid...	Biospecimen Col... Survey Administ...	6 Months - 37 Years	Children's Oncology Group
Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy	NCT06414278	Hematopoietic a... Malignant Solid...	Non-Interventio...	18 Years -	Masonic Cancer Center, University of Minnesota
Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer	NCT03223753	Carcinoma In Si... Hematopoietic a... Malignant Solid...	Educational Int... Internet-Based ... Internet-Based ... Laboratory Biom... Medical Device ... Quality-of-Life... Questionnaire A...	8 Years - 16 Years	Children's Oncology Group
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study	NCT06410209	Hematopoietic a... Malignant Solid...	Goal Setting Interview Interview Media Intervent... Medical Device ... Medical Device ... Questionnaire A... Reward Text Message-Ba... Text Message-Ba...	15 Years - 21 Years	Children's Oncology Group
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study	NCT02958462	Myeloid Maligna... Inherited Bone ... Clonal Expansio... Cytopenia Bone Marrow Fai... Clonal Cytopeni... Clonal Hematopo... Hematologic Neo... Hematopoietic a... Hereditary Neop... Idiopathic Cyto... Idiopathic Dysp... Low Risk Myelod...	Biospecimen Col... Bone Marrow Bio... Punch Biopsy Buccal Swab Clinical Evalua... Genetic Counsel... Quality-of-Life... Electronic Heal...	18 Years -	Mayo Clinic
Acupressure for Reducing Anxiety in Patients Undergoing Chemotherapy	NCT06322615	Hematopoietic a... Malignant Solid...	Acupressure The... Educational Int... Electronic Heal... Questionnaire A...	18 Years -	Mayo Clinic
Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 Trial	NCT05142241	Adrenal Gland P... Hematopoietic a... Malignant Solid... Paraganglioma	Biopsy Biospecimen Col... Computed Tomogr... Talazoparib Temozolomide	12 Years -	National Cancer Institute (NCI)
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness	NCT05691491	Advanced Malign... Advanced Micros... Hematopoietic a... Metastatic Mali... Metastatic Micr... Stage III Color... Stage IV Colore...	Biopsy Biospecimen Col... Computed Tomogr... Magnetic Resona... Temozolomide Tuvusertib	18 Years -	National Cancer Institute (NCI)
Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial	NCT04320888	Hematopoietic a... Recurrent Epend... Recurrent Ewing... Recurrent Hepat... Recurrent Histi... Recurrent Lange... Recurrent Lymph... Recurrent Malig... Recurrent Malig... Recurrent Malig... Recurrent Medul... Recurrent Neuro... Recurrent Non-H... Recurrent Osteo... Recurrent Perip... Recurrent Rhabd... Recurrent Rhabd... Recurrent Soft ... Recurrent WHO G... Refractory Epen... Refractory Ewin... Refractory Hepa... Refractory Hist... Refractory Lang... Refractory Lymp... Refractory Mali... Refractory Mali... Refractory Mali... Refractory Medu... Refractory Neur... Refractory Non-... Refractory Oste... Refractory Peri... Refractory Rhab... Refractory Rhab... Refractory Soft... Refractory WHO ... Wilms Tumor	Computed Tomogr... Magnetic Resona... Positron Emissi... Radionuclide Im... Selpercatinib X-Ray Imaging	12 Months - 21 Years	National Cancer Institute (NCI)
Testing Copanlisib as a Potential Targeted Treatment in Cancers With PIK3CA Mutations (MATCH-Subprotocol Z1F)	NCT05490771	Advanced Lympho... Advanced Malign... Hematopoietic a... Refractory Lymp... Refractory Mali... Refractory Mult...	Biopsy Computed Tomogr... Copanlisib Hydr... Magnetic Resona...	18 Years -	National Cancer Institute (NCI)
Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer	NCT05228275	COVID-19 Infect... Hematopoietic a... Malignant Solid...	Biospecimen Col... Survey Administ...	6 Months - 37 Years	Children's Oncology Group
Evaluation of 3D Surface Scanning for Virtual-CT Based Radiation Therapy Treatment Planning	NCT06409000	Hematopoietic a... Malignant Solid...	Electronic Heal... Three-Dimension...	18 Years -	Mayo Clinic
Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study	NCT06304168	Hematopoietic a... Malignant Solid...	Non-Interventio...	18 Years -	Mayo Clinic
Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation	NCT06026371	Acute Graft Ver... Hematopoietic a...	Fecal Microbiot... Placebo	18 Years -	Fred Hutchinson Cancer Center
Collection and Storage of Tissue and Blood Samples From Patients With Cancer	NCT02474160	Hematopoietic a... Malignant Solid... Metastatic Mali... Recurrent Malig...	Cytology Specim...	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: